|
GAO: FDA Meeting Performance Goals While Review Times Grow Longer
The FDA generally met its performance goals for both priority and standard NDAs and BLAs between fiscal 2000 and 2010, but the time it took the agency to review those applications has slightly increased, according to a new Government Accountability Office (GAO) report.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives